Literature DB >> 16080915

Comparative gene array analysis of TNF-alpha-induced MAPK and NF-kappaB signaling pathways between retinal ganglion cells and glial cells.

Gülgün Tezel1, Xiangjun Yang.   

Abstract

TNF-alpha has recently been identified to be a mediator of retinal ganglion cell (RGC) death, while glial cells are relatively protected against this death stimulus. To identify molecular mechanisms that control diverse responses of RGCs and glial cells to TNF-alpha, we studied differential gene expression between primary cultures of RGCs and glial cells exposed to TNF-alpha using cDNA array analysis of MAPK and NF-kappaB signaling pathways. Findings of this comparative analysis demonstrated differential regulation of various genes between RGCs and glial cells exposed to TNF-alpha. RT-PCR confirmed the differential expression of selected genes, and immunocytochemistry demonstrated gene products in cultured cells. Immunolabeling with phosphorylation site-specific antibodies also revealed differential post-translational modifications of selected proteins between cell types. Identification of signaling molecules differentially regulated in RGCs and glial cells can improve our understanding of the diverse cellular responses and provide targets for neuroprotective interventions in several neurodegenerative conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080915     DOI: 10.1016/j.exer.2005.01.022

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  17 in total

1.  Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.

Authors:  Nigar Fatma; E Kubo; M Sen; N Agarwal; W B Thoreson; C B Camras; D P Singh
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

2.  Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population.

Authors:  Muhammad Imran Khan; Shazia Micheal; Noreen Rana; Farah Akhtar; Anneke I den Hollander; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2009-12-22       Impact factor: 2.367

3.  Oxidative stress and the regulation of complement activation in human glaucoma.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Angela D Kain; David W Powell; Markus H Kuehn; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

Review 4.  Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

5.  High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Mohamadhossein Ahoor; Mehriar Nahaei; Nadereh Rashtchizadeh
Journal:  Oman Med J       Date:  2013-01

6.  TGFβ signaling induces expression of Gadd45b in retinal ganglion cells.

Authors:  Bin Liu; Xiaoguang Sun; Genn Suyeoka; Joe G N Garcia; Yannek I Leiderman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

7.  Virally delivered, constitutively active NFκB improves survival of injured retinal ganglion cells.

Authors:  Galina Dvoriantchikova; Steve Pappas; Xueting Luo; Marcio Ribeiro; Dagmara Danek; Daniel Pelaez; Kevin K Park; Dmitry Ivanov
Journal:  Eur J Neurosci       Date:  2016-09-13       Impact factor: 3.386

8.  Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells.

Authors:  Xiangjun Yang; Cheng Luo; Jian Cai; William M Pierce; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02-22       Impact factor: 4.799

Review 9.  TNF-alpha signaling in glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 10.  A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2013-02-05       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.